19 related articles for article (PubMed ID: 34985760)
1. Risk factors of developing contralateral breast cancer after first primary breast cancer treatment.
Avatefi M; HadavandSiri F; Nazari SSH; Akbari ME
Cancer Rep (Hoboken); 2024 Jan; 7(1):e1927. PubMed ID: 37919558
[TBL] [Abstract][Full Text] [Related]
2. Nonaspirin NSAIDs and contralateral breast cancer risk.
Bens A; Cronin-Fenton D; Dehlendorff C; Jensen MB; Ejlertsen B; Kroman N; Friis S; Mellemkjaer L
Int J Cancer; 2019 Mar; 144(6):1243-1250. PubMed ID: 30362513
[TBL] [Abstract][Full Text] [Related]
3. Low-dose aspirin use and risk of contralateral breast cancer: a Danish nationwide cohort study.
Bens A; Friis S; Dehlendorff C; Jensen MB; Ejlertsen B; Kroman N; Cronin-Fenton D; Mellemkjær L
Prev Med; 2018 Nov; 116():186-193. PubMed ID: 30261243
[TBL] [Abstract][Full Text] [Related]
4. Use of β-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study.
Sørensen GV; Ganz PA; Cole SW; Pedersen LA; Sørensen HT; Cronin-Fenton DP; Garne JP; Christiansen PM; Lash TL; Ahern TP
J Clin Oncol; 2013 Jun; 31(18):2265-72. PubMed ID: 23650417
[TBL] [Abstract][Full Text] [Related]
5. Mortality after contralateral breast cancer in Denmark.
Langballe R; Frederiksen K; Jensen MB; Andersson M; Cronin-Fenton D; Ejlertsen B; Mellemkjær L
Breast Cancer Res Treat; 2018 Sep; 171(2):489-499. PubMed ID: 29948403
[TBL] [Abstract][Full Text] [Related]
6. The role of H1 antihistamines in contralateral breast cancer: a Danish nationwide cohort study.
Bens A; Dehlendorff C; Friis S; Cronin-Fenton D; Jensen MB; Ejlertsen B; Lash TL; Kroman N; Mellemkjær L
Br J Cancer; 2020 Mar; 122(7):1102-1108. PubMed ID: 32063603
[TBL] [Abstract][Full Text] [Related]
7. Use of beta-blockers and risk of contralateral breast cancer.
Gottschau M; Bens A; Friis S; Cronin-Fenton D; Aalborg GL; Jensen MB; Ejlertsen B; Kroman N; Mellemkjaer L
Int J Cancer; 2022 May; 150(10):1619-1626. PubMed ID: 34985760
[TBL] [Abstract][Full Text] [Related]
8. Beta-blockers in early-stage breast cancer: a systematic review and meta-analysis.
Caparica R; Bruzzone M; Agostinetto E; De Angelis C; Fêde Â; Ceppi M; de Azambuja E
ESMO Open; 2021 Apr; 6(2):100066. PubMed ID: 33639601
[TBL] [Abstract][Full Text] [Related]
9. [Contralateral breast cancer: metastasis or second primary cancer?].
Broët P; de la Rochefordière A; Scholl SM; Fourquet A; Mosseri V; Durand JC; Pouillart P; Asselain B
Bull Cancer; 1996 Oct; 83(10):870-6. PubMed ID: 8952638
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]